Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Other Comprehensive Loss (Unaudited)

v3.20.1
Condensed Consolidated Statements of Operations and Other Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Income Statement [Abstract]    
Net sales $ 1,888 $ 2,318
Cost of sales 1,473 1,798
Gross profit 415 520
Operating expenses:    
Sales and marketing 170 266
Administration 998 1,204
Research and development 59 94
Total operating expenses 1,227 1,564
Loss from operations (812) (1,044)
Interest income, net 3 31
Net loss (809) (1,013)
Other comprehensive income:    
Unrealized gain on marketable debt securities 11 15
Total comprehensive loss $ (798) $ (998)
Basic and diluted loss per share: $ (0.07) $ (0.09)
Weighted average common shares outstanding:    
Basic and diluted 11,582,000 11,557,000